gemcitabine has been researched along with Stevens-Johnson Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cronin, M; Fox, JD; Gonzalez, AM; Kirsner, RS; Mackrides, N; Nichols, AJ; Zito, PM | 1 |
| Bui, DT; Fruehauf, JP; Holcombe, RF; Kong, KM; Sommers, KR | 1 |
| Ariad, S; Cohen, AD; Grunwald, M; Lazarev, I; Mermershtain, W | 1 |
4 other study(ies) available for gemcitabine and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Middle Aged; Skin Neoplasms; Stevens-Johnson Syndrome | 2018 |
Gemcitabine: cutaneous, hepatic and vascular disorders.
Topics: Antimetabolites, Antineoplastic; Cellulitis; Chemical and Drug Induced Liver Injury; Cytotoxins; Deoxycytidine; Drug Approval; France; Gemcitabine; Humans; Ischemia; Necrosis; Skin Diseases; Stevens-Johnson Syndrome; Vascular Diseases | 2009 |
Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient receiving concurrent radiation and gemcitabine.
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Male; Melanoma; Middle Aged; Radiography; Skin Neoplasms; Stevens-Johnson Syndrome | 2003 |
Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Stevens-Johnson Syndrome; Urinary Bladder Neoplasms | 2003 |